Sequencing and Genomic Technologies (SGT) is a basic science research core affiliated with the Duke Cancer Institute (DCI) that offers a full range of state-of-the-art genomic services. For answers to common questions, please visit our Frequently Asked Questions page.
Associate Director Devi Swain Lenz is available for project consultations.
News & Announcements
New Year, New NextSeq
The Sequencing and Genomic Technologies core facility has acquired a new sequencing platform. The llumina NextSeq 1000 produces 100-400 M reads at a variety of read lengths, including 300 bp paired-end reads at a fraction of the price of the NextSeq 500 and MiSeq.
Illumina Bacterial Isolate Re-Sequencing Workshop Using the Illumina DNA Library Prep Kit
SGT to host PacBio for Long Read Sequencing seminar
Join the Sequencing and Genomic Technologies (SGT) Core Facility as they host PacBio for a seminar about long read sequencing. Attendees can join in person or via Zoom.
